Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion

24Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Background: Kinesin family member 26B (KIF26B) plays a key role in the development and progression of many human cancers. However, the role and underlying mechanisms of KIF26B in breast cancer cells remain unknown. Materials and methods: In this study, we inhibited the expression of KIF26B in MDA-MB-231 and MCF-7 cells using lentivirus-delivered shRNA. Results: Lentivirus-mediated KIF26B knockdown significantly suppressed cell proliferation, colony formation, migration, and invasion. Furthermore, cell cycle analyses revealed that the percentage of cells in the G0/G1 phase was significantly increased in KIF26B knockdown cells. Moreover, the knockdown of KIF26B significantly promoted cell apoptosis via the upregulation of cleaved caspase-3 and Bax. Conclusion: Our data indicate that KIF26B plays a pivotal role in tumor growth and metastasis in breast cancer cells and may be a potential therapeutic target for treating breast cancer.

Cite

CITATION STYLE

APA

Gu, S., Liang, H., Qi, D., Liyan Mao, Mao, G., Qian, L., & Zhang, S. (2018). Knockdown of KIF26B inhibits breast cancer cell proliferation, migration, and invasion. OncoTargets and Therapy, 11, 3195–3203. https://doi.org/10.2147/OTT.S163346

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free